Stueland Katherine sold WGS
September 30, 2025 · Form 4 insider transaction
Stueland Katherine sold 554 shares of GeneDx Holdings Corp. at $109.13 per share, a transaction worth $60.5K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
554
Price
$109.13
Total value
$60.5K
InsiderStueland Katherine
RoleOfficer, Director
CompanyGeneDx Holdings Corp. (WGS)
SecurityClass A Common Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 30, 2025
Filing dateOctober 1, 2025
Shares owned after2,701
OwnershipDirect
10b5-1 planYes
AmendedNo
Footnotes
The reported transaction represents a sale effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on August 16, 2024.; The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $109.00 to $109.3837, inclusive.